Extracellular annexin-A1 promotes myeloid/granulocytic differentiation of hematopoietic stem/progenitor cells via the Ca
Calcium signalling
Recombinant protein therapy
Journal
Cell death discovery
ISSN: 2058-7716
Titre abrégé: Cell Death Discov
Pays: United States
ID NLM: 101665035
Informations de publication
Date de publication:
2019
2019
Historique:
received:
29
05
2019
revised:
19
07
2019
accepted:
24
08
2019
entrez:
26
9
2019
pubmed:
26
9
2019
medline:
26
9
2019
Statut:
epublish
Résumé
Annexin A1 (AnxA1) modulates neutrophil life span and bone marrow/blood cell trafficking thorough activation of formyl-peptide receptors (FPRs). Here, we investigated the effect of exogenous AnxA1 on haematopoiesis in the mouse. Treatment of C57BL/6 mice with recombinant AnxA1 (rAnxA1) reduced the granulocyte-macrophage progenitor (GMP) population in the bone marrow, enhanced the number of mature granulocytes Gr-1
Identifiants
pubmed: 31552142
doi: 10.1038/s41420-019-0215-1
pii: 215
pmc: PMC6755131
doi:
Types de publication
Journal Article
Langues
eng
Pagination
135Déclaration de conflit d'intérêts
Conflict of interestThe authors declare that they have no conflict of interest.
Références
Science. 2000 Feb 25;287(5457):1442-6
pubmed: 10688785
Nature. 2000 Mar 9;404(6774):193-7
pubmed: 10724173
J Immunol. 2001 Nov 1;167(9):4805-13
pubmed: 11673483
Physiol Rev. 2002 Apr;82(2):331-71
pubmed: 11917092
Immunity. 2003 Dec;19(6):781-91
pubmed: 14670296
J Biol Chem. 2004 Oct 1;279(40):41807-14
pubmed: 15258148
FASEB J. 2005 Jan;19(1):100-2
pubmed: 15507472
Nat Immunol. 2005 Mar;6(3):314-22
pubmed: 15665828
Cell Death Differ. 2005 Oct;12(10):1358-60
pubmed: 15846370
Nat Rev Mol Cell Biol. 2005 Jun;6(6):449-61
pubmed: 15928709
J Biol Chem. 2005 Sep 30;280(39):33101-8
pubmed: 16020540
Blood. 2006 Mar 1;107(5):2123-30
pubmed: 16278303
Cytokine Growth Factor Rev. 2006 Dec;17(6):501-19
pubmed: 17084101
ScientificWorldJournal. 2006 Dec 06;6:1555-73
pubmed: 17160341
Leukemia. 2007 Jul;21(7):1363-77
pubmed: 17443228
Eur J Immunol. 2007 Nov;37(11):3131-42
pubmed: 17948261
Immunity. 2008 Sep 19;29(3):487-96
pubmed: 18718768
J Biol Chem. 2008 Nov 14;283(46):31909-19
pubmed: 18775989
FASEB J. 2009 Apr;23(4):985-96
pubmed: 19029200
Nat Rev Immunol. 2009 Jan;9(1):62-70
pubmed: 19104500
FASEB J. 2010 Nov;24(11):4240-9
pubmed: 20570963
J Immunol. 2010 Sep 1;185(5):2927-34
pubmed: 20679530
EMBO Mol Med. 2011 Feb;3(2):102-14
pubmed: 21254404
Cell Death Dis. 2011 Jun 02;2:e165
pubmed: 21633388
Nat Immunol. 2011 Jun 26;12(8):761-9
pubmed: 21706006
FASEB J. 2012 Jan;26(1):387-96
pubmed: 21957127
Nat Immunol. 2011 Dec 25;13(2):170-80
pubmed: 22197976
J Biol Chem. 2012 Jul 13;287(29):24690-7
pubmed: 22610094
Adv Hematol. 2012;2012:398640
pubmed: 22844288
J Leukoc Biol. 2013 Oct;94(4):677-82
pubmed: 23630389
J Immunol. 2013 Oct 15;191(8):4348-57
pubmed: 24026079
J Cell Biochem. 2014 Jan;115(1):42-51
pubmed: 24038146
Proc Natl Acad Sci U S A. 2013 Nov 5;110(45):18232-7
pubmed: 24108355
Nat Immunol. 2014 Jul;15(7):602-11
pubmed: 24940954
Stem Cells. 2014 Nov;32(11):2949-60
pubmed: 24964894
Cytokine Growth Factor Rev. 2014 Aug;25(4):355-67
pubmed: 25131807
Semin Immunol. 2015 May;27(3):149-60
pubmed: 25911383
J Immunol Res. 2016;2016:8239258
pubmed: 26885535
J Cell Physiol. 2016 Nov;231(11):2418-27
pubmed: 26892496
J Exp Med. 2016 Jul 25;213(8):1537-53
pubmed: 27432941
Proc Natl Acad Sci U S A. 2016 Oct 4;113(40):11300-11305
pubmed: 27651484
Nat Immunol. 2016 Dec;17(12):1407-1414
pubmed: 27798616
Nat Cell Biol. 2017 Mar;19(3):214-223
pubmed: 28218906
Curr Stem Cell Rep. 2017;3(3):202-209
pubmed: 28845387
Blood. 2018 Jan 25;131(4):439-449
pubmed: 29371208
Exp Cell Res. 2018 Jun 15;367(2):282-290
pubmed: 29649428
BMB Rep. 2018 Aug;51(8):418-423
pubmed: 30021674
Immunology. 2019 Jan;156(1):23-32
pubmed: 30259972
Front Immunol. 2019 Jan 29;10:105
pubmed: 30761151
Front Cardiovasc Med. 2019 Mar 18;6:25
pubmed: 30937305
J Immunol Res. 2019 Feb 28;2019:8016254
pubmed: 30944838
Biomedicine. 1977 Dec;27(9-10):344-9
pubmed: 606310
Blood. 1994 Apr 15;83(8):2057-62
pubmed: 7512837